Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=20339174&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Pylorus preserving pancreaticoduodenectomy for peri-ampullary carcinoma, is it a good option?Alsaif FSaudi J Gastroenterol 2010[Apr]; 16 (2): 75-8Pancreaticoduodenectomy (PD) is the standard surgical treatment for resectable peri-ampullary tumors. It can be performed with or without pylorus preservation. Many surgeons have a negative opinion of pylorus preserving PD (PPPD) and consider it an inferior operation, especially from an oncological point of view. This article reviews the various aspects of PD in the context of operative factors like blood loss and operation time, complications such as delayed gastric emptying and anastomotic leaks, and the impact on quality of life and survival. We aim to show that PPPD is at least as good as classic PD, if not better in some aspects.|*Pylorus[MESH]|Ampulla of Vater/pathology/surgery[MESH]|Anastomosis, Surgical/adverse effects/methods[MESH]|Blood Loss, Surgical[MESH]|Blood Transfusion[MESH]|Carcinoma/*mortality/pathology/*surgery[MESH]|Female[MESH]|Follow-Up Studies[MESH]|Gastric Emptying/physiology[MESH]|Hospital Mortality/trends[MESH]|Humans[MESH]|Intraoperative Complications/mortality[MESH]|Length of Stay[MESH]|Male[MESH]|Neoplasm Recurrence, Local/mortality/pathology[MESH]|Pancreatic Neoplasms/*mortality/pathology/*surgery[MESH]|Pancreaticoduodenectomy/*methods/mortality[MESH]|Postoperative Complications/mortality/prevention & control[MESH]|Randomized Controlled Trials as Topic[MESH]|Survival Analysis[MESH]|Treatment Outcome[MESH] |
